Kidney Today Blog
Our blog brings you voices from the fight against kidney disease — patients, their loved ones, renal professionals, and many others.
- Featured posts
- All posts
Loading...
1 Results
Blog post
In January 2025, FDA approved an injectable form of semaglutide (GLP1-RA) to treat CKD in people with type 2 diabetes. Here are 6 important things you need to know about GLP1-RAs, CKD and the FDA approval.